Activation of the p53 pathway by the MDM2 inhibitor nutlin-3a overcomes BCL2 overexpression in a preclinical model of diffuse large B-cell lymphoma associated with t(14;18)(q32;q21)Ηλίας Δράκος, L. Jeffrey Medeiros|Leukemia|2011Cited by 66